A clinical overview of people living with HIV and genitourinary cancer care
- 18 January 2024
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 21 (6) , 373-383
Abstract
The number of people living with HIV infection has been increasing globally. Administration of antiretroviral therapy is effective in controlling the infection for most patients and, as a consequence, people living with HIV (PLWH) now often have a long life expectancy. However, their risk of developing cancer — most notably virus-related cancers — has been increasing. To date, few studies have assessed the risk of genitourinary cancers in PLWH, and robust scientific data on their treatment-related outcomes are lacking. Previous studies have noted that PLWH are at a reduced risk of prostate cancer; however, low adoption and/or availability of prostate cancer screening among these patients might be confounding the validity of this finding. In genitourinary cancers, advanced stage at diagnosis and reduced cancer-specific mortality have been reported in PLWH. These data likely reflect, at least in part, the inequity of health care access for PLWH. Notably, systemic chemotherapy and/or radiotherapy could decrease total CD4+ cell counts, which could, therefore, increase the risk of morbidity and mortality from cancer treatments in PLWH. Immune checkpoint inhibitors have become the therapeutic backbone for many advanced malignancies in the general population; however, most studies validating their efficacy have excluded PLWH owing to concerns of severe adverse effects from immune checkpoint inhibitors themselves and/or related to their immunosuppressed status. To our knowledge, no genitourinary cancer survivorship programme exists that specifically caters to the needs of PLWH. By including PLWH in ongoing cancer trials, we can gain invaluable insights that will help to improve cancer care specifically for PLWH.Keywords
This publication has 136 references indexed in Scilit:
- The Strong Protective Effect of Circumcision against Cancer of the PenisAdvances in Urology, 2011
- Reduced Risk of Prostate Cancer in U.S. Men with AIDSCancer Epidemiology, Biomarkers & Prevention, 2010
- Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyBritish Journal of Cancer, 2010
- A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- HIV infection and the risk of cancers with and without a known infectious causeAIDS, 2009
- Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapyAIDS, 2009
- HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and managementBMC Urology, 2009
- Serum prostate‐specific antigen levels in older men with or at risk of HIV infectionHIV Medicine, 2006
- Radical prostatectomy in patients infected with human immunodeficiency virusBJU International, 2006
- Interactions Between Antiretrovirals and Antineoplastic Drug TherapyClinical Pharmacokinetics, 2005